Q32 Bio Inc. (QTTB) Invested Capital (2023 - 2026)

Q32 Bio has reported Invested Capital for 4 years, with the latest figure at $105.9 million in Q2 2026.

• On a quarterly basis, Invested Capital rose 20464.08% year-over-year to $105.9 million in Q2 2026; TTM through Jun 2026 was $105.9 million, a 20464.08% increase from a year earlier, with the FY2025 full-year figure at $51.7 million, up 182.2% from the prior year.
• Invested Capital was $105.9 million for Q2 2026 at Q32 Bio, up from $54.5 million in the prior quarter.
• The five-year high for Invested Capital was $105.9 million in Q2 2026, with the low at -$177.5 million in Q4 2023.
• Average Invested Capital over 4 years is $17.6 million, with a median of $30.9 million recorded in 2024.
• The sharpest annual moves came in 2025 and 2026: Invested Capital sank 123.35% in 2025, then surged 20464.08% in 2026.
• Over 4 years, Invested Capital stood at -$177.5 million in 2023, then soared by 110.33% to $18.3 million in 2024, then surged by 182.2% to $51.7 million in 2025, then jumped by 104.76% to $105.9 million in 2026.
• The last three Invested Capital figures came in at $105.9 million (Q2 2026), $54.5 million (Q1 2026), and $51.7 million (Q4 2025), per Business Quant data.